Gene Therapy with Modified Autologous Hematopoietic Stem Cells for Patients with Mucopolysaccharidosis Type II
Research area:
Rare disease
Disease:
Intervention:
Phase:
Related news
Dementia Consortium funds Manchester based team targeting immune system in search for new dementia treatments